Publications by authors named "Fabio Forghieri"

Claim this Profile
P
Pegaspargase administration and tolerability in patients aged 55 years or older with acute lymphoblastic leukemia treated with the LAL1913 program. A subanalysis of the Campus ALL group.
Davide Lazzarotto, Anna Maria Testi, Matteo Fanin, Federico Mosna, Sabina Chiaretti, Fabio Forghieri

Ann Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of allogeneic stem cell transplant in adult Philadelphia negative acute lymphoblastic leukemia patients treated with the pediatric-inspired GIMEMA 1913 protocol. A Campus ALL study.
Gianluca Cavallaro, Davide Lazzarotto, Chiara Pavoni, Francesca Valsecchi, Anna Grassi, Fabio Forghieri

Bone Marrow Transplant· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real World Incidence and Etiology of Infectious Complications in Adults With Ph-Negative Acute Lymphoblastic Leukemia Treated With the Pediatric-Inspired GIMEMA LAL1913 Program. A Campus All Study.
Patrizia Zappasodi, Ludovica Calabretta, Virginia Valeria Ferretti, Davide Lazzarotto, Nicola Fracchiolla, Fabio Forghieri

Hematol Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Palliative Care, Goals of Care Conversations and Quality EOL Care in Acute Leukemia and HR-MDS.
Leonardo Potenza, Davide Giusti, Eleonora Borelli, Elisabetta Colaci, Federico Banchelli, Fabio Forghieri

J Pain Symptom Manage· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy.
Federico Mosna, Erika Borlenghi, Mark Litzow, John C Byrd, Cristina Papayannidis, Fabio Forghieri

Haematologica· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study.
Davide Lazzarotto, Marco Cerrano, Cristina Papayannidis, Sabina Chiaretti, Federico Mosna, Fabio Forghieri

Haematologica· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia.
Rossana Maffei, Ambra Paolini, Benedetta Conte, Giovanni Riva, Vincenzo Nasillo, Fabio Forghieri

Ann Hematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of latent tuberculosis infection (LTBI) in adult patients with newly diagnosed acute leukemia: results of a survey among Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group.
Fabio Forghieri, Francesca Bettelli, Simona Sgromo, Gianpaolo Nadali, Maria Ilaria Del Principe

Ann Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral prophylaxis to prevent herpes simplex virus (HSV) and varicella zoster virus (VZV) reactivation in adult patients with newly diagnosed acute leukemia: results of a survey submitted to Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group.
Fabio Forghieri, Stefano Cordella, Francesco Marchesi, Federico Itri, Maria Ilaria Del Principe

Ann Hematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary acute myeloid leukemia and early infection are independent predictors of poor survival in acute myeloid leukemia treated with hypomethylating agents and venetoclax.
Stefano Cordella, Davide Giusti, Eleonora De Bellis, Michelina Dargenio, Federica Creti', Fabio Forghieri

Hematol Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early palliative care versus usual haematological care in multiple myeloma: retrospective cohort study.
Davide Giusti, Elisabetta Colaci, Valeria Pioli, Federico Banchelli, Monica Maccaferri, Fabio Forghieri

BMJ Support Palliat Care· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients.
Francesca Bettelli, Daniela Vallerini, Ivana Lagreca, Patrizia Barozzi, Giovanni Riva, Fabio Forghieri

PLoS One· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and clinical behavior of acute myeloid leukemia harboring rare non-A/B/D nucleophosmin () gene mutation subtypes: a single-center experience and review of the literature.
Martina Mutti, Stefano Cordella, Angelica Parisotto, Francesca Bettelli, Monica Morselli, Fabio Forghieri

Leuk Lymphoma· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 omicron variant outbreak in a hematopoietic stem cell transplant unit.
Andrea Gilioli, Paola Bresciani, Erica Franceschini, Andrea Messerotti, Valeria Pioli, Fabio Forghieri

Int J Hematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL study.
Darina Ocadlikova, Federico Lussana, Nicola Fracchiolla, Massimiliano Bonifacio, Lidia Santoro, Fabio Forghieri

Br J Haematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vancomycin resistant enterococcus risk factors for hospital colonization in hematological patients: a matched case-control study.
Marianna Meschiari, Shaniko Kaleci, Martina Del Monte, Andrea Dessilani, Antonella Santoro, Fabio Forghieri

Antimicrob Resist Infect Control· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study.
Nicola Stefano Fracchiolla, Mariarita Sciumè, Cristina Papayannidis, Antonella Vitale, Sabina Chiaretti, Fabio Forghieri

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dynamic functions of IRF4 in B cell malignancies.
Rossana Maffei, Stefania Fiorcari, Claudio Giacinto Atene, Silvia Martinelli, Nicolò Mesini, Fabio Forghieri

Clin Exp Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved efficacy of quizartinib in combination therapy with PI3K inhibition in primary FLT3-ITD AML cells.
Salihanur Darici, Heather G Jørgensen, Xu Huang, Valentina Serafin, Ludovica Antolini, Fabio Forghieri

Adv Biol Regul· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study.
Davide Lazzarotto, Ilaria Tanasi, Antonella Vitale, Matteo Piccini, Michelina Dargenio, Fabio Forghieri

Ann Hematol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1) for the Treatment of NPM1-Acute Myeloid Leukemia.
Marica De Cicco, Ivana Lagreca, Sabrina Basso, Patrizia Barozzi, Stella Muscianisi, Fabio Forghieri

Cancers (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL study.
Michelina Dargenio, Massimiliano Bonifacio, Sabina Chiaretti, Antonella Vitale, Nicola Stefano Fracchiolla, Fabio Forghieri

Br J Haematol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies.
Ivana Lagreca, Vincenzo Nasillo, Patrizia Barozzi, Ilaria Castelli, Sabrina Basso, Fabio Forghieri

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience.
Stefano Cordella, Angelica Parisotto, Francesca Bettelli, Monica Morselli, Emiliano Barbieri, Fabio Forghieri

Ann Hematol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levocarnitine supplementation for asparaginase-induced hepatotoxicity in adult acute lymphoblastic leukemia patients: A multicenter observational study of the campus all group.
Marzia Defina, Davide Lazzarotto, Fabio Guolo, Paola Minetto, Nicola Stefano Fracchiolla, Fabio Forghieri

Leuk Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis